Simplex Trading
LFCR icon

Simplex Trading’s Lifecore Biomedical LFCR Stock Holding History

Simplex Trading’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32K Sell
6,100
-3,300
-35% -$16.6K ﹤0.01% 6696
2026
Q1 		$35K Sell
9,400
-5,600
-37% -$38.7K ﹤0.01% 6235
2025
Q4 		$123K Buy
15,000
+3,500
+30% +$25.9K ﹤0.01% 4771
2025
Q3 		$84K Buy
11,500
+9,800
+576% +$74.2K ﹤0.01% 5943
2025
Q2 		$13K Buy
1,700
+1,400
+467% +$9.44K ﹤0.01% 7113
2025
Q1 		$2K Sell
300
-100
-25% -$621 ﹤0.01% 8010
2024
Q4 		$2K Sell
400
-3,700
-90% -$23.6K ﹤0.01% 8026
2024
Q3 		$20K Buy
+4,100
New +$21.4K ﹤0.01% 6675
2024
Q2 		– Sell
-3,000
Closed -$15K – 9352
2024
Q1 		$15K Sell
3,000
-3,400
-53% -$24.3K ﹤0.01% 7325
2023
Q4 		$39K Sell
6,400
-8,000
-56% -$55.5K ﹤0.01% 6327
2023
Q3 		$108K Sell
14,400
-123,100
-90% -$1.13M ﹤0.01% 5003
2023
Q2 		$1.33M Buy
137,500
+134,100
+3,944% +$819K ﹤0.01% 2329
2023
Q1 		$12K Sell
3,400
-22,000
-87% -$123K ﹤0.01% 7380
2022
Q4 		$164K Buy
+25,400
New +$209K ﹤0.01% 4478
2022
Q1 		– Sell
-100
Closed -$1K – 10953
2021
Q4 		$1K Buy
+100
New +$970 ﹤0.01% 10201
2021
Q1 		– Sell
-24
Closed -$26K – 9450
2020
Q4 		$26K Buy
24
+9
+60% +$93 ﹤0.01% 6786
2020
Q3 		$14K Buy
15
+1
+7% +$10 ﹤0.01% 6608
2020
Q2 		$11K Buy
+14
New +$144 ﹤0.01% 6599
2019
Q1 		– Sell
-10
Closed -$11K – 7490
2018
Q4 		$11K Hold
10
– – ﹤0.01% 5784
2018
Q3 		$14K Buy
+10
New +$138 ﹤0.01% 6230

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Simplex Trading's LFCR Position: Q2 2026 in Review

Simplex Trading increased its Lifecore Biomedical (LFCR) stake by 295% in Q2 2026, buying an estimated $93.3K and bringing the position to 24,789 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #5243.

Simplex Trading first reported a position in LFCR in Q4 2016 and has held it in 27 quarters since. The position peaked at $534K in Q2 2023. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Simplex Trading held 24,789 shares of Lifecore Biomedical worth $130K as of Q2 2026.
  • Simplex Trading bought 18,512 Lifecore Biomedical shares in Q2 2026, an estimated $93.3K.
  • Lifecore Biomedical made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5243 holding.
  • Simplex Trading first reported a position in Lifecore Biomedical in Q4 2016 and has held it in 27 quarters since.
  • Simplex Trading's Lifecore Biomedical position peaked at $534K in Q2 2023.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.